Bigmar, Inc. (Nasdaq SmallCap: BGMR) has received approval from the Intercantonal Office for the Control of Medicine (IKS) in Switzerland to utilize IV bags as a drug delivery system for Metronidazole, an antibiotic used in the treatment of serious infections caused by anaerobic bacteria. This approval allows Bigmar to manufacture and market IV bags formulated with Metronidazole within Switzerland.
The company also filed for approval from the IKS for the formulation of ...